Cytokines and acute phase response in delirium

Journal of Psychosomatic Research

Volumn 62, Issue 5, 2007, Pages 521-525

  de Rooij, Sophia E ^a   van Munster, Barbara C ^a   Korevaar, Johanna C ^a   Levi, Marcel ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Cytokines; Delirium; Elderly; Hospital admission; Immunology

Indexed keywords

C REACTIVE PROTEIN; CYTOKINE; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; TUMOR NECROSIS FACTOR ALPHA;

AGED; ANALYTIC METHOD; ARTICLE; COGNITION; COMPARATIVE STUDY; CONTROLLED STUDY; DELIRIUM; FEMALE; FUNCTIONAL ASSESSMENT; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; MEMORY; PATHOGENESIS; TEACHING HOSPITAL; VALIDATION PROCESS;

ACTIVITIES OF DAILY LIVING; ACUTE-PHASE REACTION; AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; CYTOKINES; DELIRIUM; DISABILITY EVALUATION; FEMALE; GERIATRIC ASSESSMENT; HUMANS; INTERLEUKIN-6; INTERLEUKIN-8; MALE; MENTAL STATUS SCHEDULE; PATIENT ADMISSION; PATIENT CARE TEAM; REFERENCE VALUES;

EID: 34247352809     PISSN: 00223999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpsychores.2006.11.013     Document Type: Article

References (40)

1. Crestani F., Seguy F., and Dantzer R. Behavioural effects of peripherally injected interleukin-1: role of prostaglandins. Brain Res 542 (1991) 330-335
2. Konsman J., Blond D., and Vigues S. Neurobiology of interleukin-1 receptors: getting the message. Eur Cytokine Netw 11 (2000) 699-702
3. Dantzer R. Cytokine-induced sickness behaviour: a neuroimmune response to activation of innate immunity. Eur J Pharmacol 500 (2004) 399-411
4. Dantzer R., Konsman J., Bluthe R., et al. Neural and humoral pathways of communication from the immune system to the brain: parallel or convergent?. Auton Neurosci 85 (2000) 60-65
5. Konsman J., Parnet P., and Dantzer R. Cytokine-induced sickness behaviour: mechanisms and implications. Trends Neurosci 5 (2002) 154-159
6. Dantzer R., Bluthe R., Laye S., et al. Cytokines and sickness behavior. Ann N Y Acad Sci 1840 (1998) 586-590
7. Anforth H., Bluthe R., Bristow A., et al. Biological activity and brain actions of recombinant rat interleukin-1alpha and interleukin-1beta. Eur Cytokine Netw 9 (1998) 279-288
8. Kalman J., Juhasz A., Laird G., et al. Serum interleukin-6 levels correlate with the severity of dementia in Down syndrome and in Alzheimer's disease. Acta Neurol Scand 96 (1997) 236-240
9. Kahl K., Bens S., Ziegler K., et al. Cortisol, the cortisol-dehydroepiandrosterone ratio, and pro-inflammatory cytokines in patients with current major depressive disorder comorbid with borderline personality disorder. Biol Psychiatry 59 (2006) 667-671
10. Meyers C. Mood and cognitive disorders in cancer patients receiving cytokine therapy. Adv Exp Med Biol 461 (1999) 75-81
11. Meyers C., Albitar M., and Estey E. Cognitive impairment, fatigue, and cytokine levels in patients with acute myelogenous leukemia or myelodysplastic syndrome. Cancer 104 (2005) 788-793
12. Eikelenboom P., Hoogendijk W., Jonker C., et al. Immunological mechanisms and the spectrum of psychiatric syndromes in Alzheimer's disease. J Psychiatr Res 36 (2002) 269-280
13. Stefano G., Bilfinger T., and Fricchione G. The immune-neuro-link and the macrophage: postcardiotomy delirium, HIV-associated dementia and psychiatry. Prog Neurobiol 42 (1994) 475-488
14. George J., Bleasdale S., and Singleton S. Causes and prognosis of delirium in elderly patients admitted to a district general hospital. Age Ageing 26 (1997) 423-427
15. Manos P., and Wu R. The duration of delirium in medical and postoperative patients referred for psychiatric consultation. Ann Clin Psychiatry 9 (1997) 219-226
16. Willard L., Hauss-Wegrzyniak B., and Wenk G. Pathological and biochemical consequences of acute and chronic neuroinflammation within the basal forebrain cholinergic system of rats. Neuroscience 88 (1999) 193-200
17. Flacker J., and Lipsitz L. Serum anticholinergic activity changes with acute illness in elderly medical patients. J Gerontol A Biol Sci Med Sci 54 (1999) M12-M16
18. Dunlop R., and Campbell C. Cytokines and advanced cancer. J Pain Symptom Manage 20 (2000) 214-232
19. Watkins L., Maier S., and Goehler L. Cytokine-to-brain communication: a review & analysis of alternative mechanisms. Life Sci 57 (1995) 1011-1026
20. Eikelenboom P., and Hoogendijk W. Do delirium and Alzheimer's dementia share specific pathogenetic mechanisms?. Dement Geriatr Cogn Disord 10 (1999) 319-324
21. Eikelenboom P., Rozemuller J., and van Muiswinkel F. Inflammation and Alzheimer's disease: relationships between pathogenic mechanisms and clinical expression. Exp Neurol 154 (1998) 89-98
22. Folstein M., Folstein S., and McHugh P. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12 (1975) 189-198
23. Jorm A., and Jacomb P. The Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE): socio-demographic correlates, reliability, validity and some norms. Psychol Med 19 (1989) 1015-1022
24. Jorm A., Scott R., Cullen J., et al. Performance of the Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE) as a screening test for dementia. Psychol Med 21 (1991) 785-790
25. Inouye S.K., van Dyck S.K., Alessi C.H., et al. Clarifying confusion: the confusion assessment method. A new method for detection of delirium. Ann Intern Med 113 (1990) 941-948
26. de Rooij S., van Munster B., Korevaar J., Casteelen G., Schuurmans M., and van der Mast R. Delirium subtype identification and the validation of the delirium rating scale-revised-98 (Dutch version) in hospitalized elderly patients. Int J Geriatr Psychiatry 21 (2006) 876-882
27. Weinberger M., Samsa G., Schmader K., et al. Comparing proxy and patients' perceptions of patients' functional status: results from an outpatient geriatric clinic. J Am Geriatr Soc 40 (1992) 585-588
28. Wilson K., Broadhurst C., Diver M., et al. Plasma insulin growth factor-1 and incident delirium in older people. Int J Geriatr Psychiatry 20 (2005) 154-159
29. Holmes C., El-Okl M., Williams A., et al. Systemic infection, interleukin 1beta, and cognitive decline in Alzheimer's disease. J Neurol Neurosurg Psychiatry 74 (2003) 788-789
30. Teunissen C., van Boxtel M., Bosma H., et al. Inflammation markers in relation to cognition in a healthy aging population. J Neuroimmunol 134 (2003) 142-150
31. Weaver J., Huang M., Albert M., et al. Interleukin-6 and risk of cognitive decline: MacArthur studies of successful aging. Neurology 59 (2002) 371-378
32. Yaffe K., Lindquist K., Penninx B., et al. Inflammatory markers and cognition in well-functioning African-American and white elders. Neurology 61 (2003) 76-80
33. Breitbart W., Gibson C., and Tremblay A. The delirium experience: delirium recall and delirium-related distress in hospitalized patients with cancer, their spouses/caregivers, and their nurses. Psychosomatics 43 (2002) 183-194
34. Lipowski Z. Delirium in the elderly patient. N Engl J Med 320 (1989) 578-582
35. Trzepacz P. Update on the neuropathogenesis of delirium. Dement Geriatr Cogn Disord 10 (1999) 330-334
36. Gibson G., Blass J., Huang H., et al. The cellular basis of delirium and its relevance to age-related disorders including Alzheimer's disease. Int Psychogeriatr 3 (1991) 373-395
37. Kalman J., Juhasz A., Bogats G., et al. Elevated levels of inflammatory biomarkers in the cerebrospinal fluid after coronary artery bypass surgery are predictors of cognitive decline. Neurochem Int 48 (2006) 177-180
38. Kobayashi K., Takeuchi O., Suzuki M., et al. A retrospective study on delirium type. Jpn J Psychiatry Neurol 46 (1992) 911-917
39. Pollmacher T., Haack M., Schuld A., et al. Low levels of circulating inflammatory cytokines-do they affect human brain functions?. Brain Behav Immun 16 (2002) 525-532
40. Haack M., Hinze-Selch D., Fenzel T., et al. Plasma levels of cytokines and soluble cytokine receptors in psychiatric patients upon hospital admission: effects of confounding factors and diagnosis. J Psychiatr Res 33 (1999) 407-418